Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte K Brierley

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|August 4, 2018
Autoimmune cytopenias and thrombotic thrombocytopenic purpuraCharlotte K Brierley, Sue Pavord
Current Opinion in Oncology|January 3, 2020
Single-cell sequencing in hematologyCharlotte K Brierley, Adam J Mead
British Journal of Haematology|February 10, 2015
Thrombopoiesis-stimulating agents and myelodysplastic syndromesCharlotte K Brierley, David P Steensma
Current Hematologic Malignancy Reports|August 6, 2016
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid NeoplasmsCharlotte K Brierley, David P Steensma
Current Opinion in Hematology|December 31, 2015
Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?Charlotte K Brierley, David P Steensma
The American Journal of Tropical Medicine and Hygiene|November 27, 2013
Healthcare access and health beliefs of the indigenous peoples in remote Amazonian PeruCharlotte K Brierley, Nicolas Suarez, Gitanjli Arora, et al.
Cancer|August 9, 2020
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromesCharlotte K Brierley, Emily C Zabor, Rami S Komrokji, et al.
British Journal of Haematology|November 24, 2018
Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignanciesCharlotte K Brierley, Francesca M Jones, Katharine Hanlon, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Science Translational Medicine|July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosisAlexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|August 4, 2018
Autoimmune cytopenias and thrombotic thrombocytopenic purpuraCharlotte K Brierley, Sue Pavord
Current Opinion in Oncology|January 3, 2020
Single-cell sequencing in hematologyCharlotte K Brierley, Adam J Mead
British Journal of Haematology|February 10, 2015
Thrombopoiesis-stimulating agents and myelodysplastic syndromesCharlotte K Brierley, David P Steensma
Current Hematologic Malignancy Reports|August 6, 2016
Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid NeoplasmsCharlotte K Brierley, David P Steensma
Current Opinion in Hematology|December 31, 2015
Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter?Charlotte K Brierley, David P Steensma
The American Journal of Tropical Medicine and Hygiene|November 27, 2013
Healthcare access and health beliefs of the indigenous peoples in remote Amazonian PeruCharlotte K Brierley, Nicolas Suarez, Gitanjli Arora, et al.
Cancer|August 9, 2020
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromesCharlotte K Brierley, Emily C Zabor, Rami S Komrokji, et al.
British Journal of Haematology|November 24, 2018
Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignanciesCharlotte K Brierley, Francesca M Jones, Katharine Hanlon, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Science Translational Medicine|July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosisAlexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Pageof 2